Lindbrook Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $151K | Buy |
1,100
+476
| +76% | +$65.1K | 0.01% | 512 |
|
|
2024
Q4 | $95.4K | Buy |
624
+32
| +5% | +$4.89K | 0.01% | 573 |
|
|
2024
Q3 | $115K | Sell |
592
-135
| -19% | -$26.2K | 0.01% | 526 |
|
|
2024
Q2 | $169K | Buy |
727
+186
| +34% | +$43.1K | 0.02% | 394 |
|
|
2024
Q1 | $117K | Hold |
541
| – | – | 0.01% | 493 |
|
|
2023
Q4 | $140K | Sell |
541
-81
| -13% | -$21K | 0.01% | 427 |
|
|
2023
Q3 | $160K | Sell |
622
-91
| -13% | -$23.4K | 0.02% | 367 |
|
|
2023
Q2 | $203K | Buy |
713
+14
| +2% | +$3.99K | 0.02% | 321 |
|
|
2023
Q1 | $194K | Buy |
699
+130
| +23% | +$36.1K | 0.02% | 319 |
|
|
2022
Q4 | $158K | Buy |
569
+47
| +9% | +$13K | 0.02% | 385 |
|
|
2022
Q3 | $139K | Buy |
522
+77
| +17% | +$20.5K | 0.02% | 354 |
|
|
2022
Q2 | $91K | Sell |
445
-239
| -35% | -$48.9K | 0.02% | 462 |
|
|
2022
Q1 | $144K | Buy |
684
+202
| +42% | +$42.5K | 0.02% | 366 |
|
|
2021
Q4 | $116K | Buy |
482
+236
| +96% | +$56.8K | 0.02% | 453 |
|
|
2021
Q3 | $70K | Sell |
246
-93
| -27% | -$26.5K | 0.02% | 350 |
|
|
2021
Q2 | $117K | Buy |
339
+111
| +49% | +$38.3K | 0.03% | 256 |
|
|
2021
Q1 | $64K | Buy |
228
+30
| +15% | +$8.42K | 0.01% | 364 |
|
|
2020
Q4 | $48K | Sell |
198
-12
| -6% | -$2.91K | 0.01% | 407 |
|
|
2020
Q3 | $60K | Sell |
210
-16
| -7% | -$4.57K | 0.02% | 310 |
|
|
2020
Q2 | $60K | Sell |
226
-38
| -14% | -$10.1K | 0.02% | 322 |
|
|
2020
Q1 | $84K | Buy |
264
+29
| +12% | +$9.23K | 0.03% | 210 |
|
|
2019
Q4 | $70K | Buy |
235
+17
| +8% | +$5.06K | 0.02% | 340 |
|
|
2019
Q3 | $51K | Sell |
218
-5
| -2% | -$1.17K | 0.02% | 410 |
|
|
2019
Q2 | $52K | Sell |
223
-994
| -82% | -$232K | 0.02% | 410 |
|
|
2019
Q1 | $287K | Buy |
1,217
+43
| +4% | +$10.1K | 0.11% | 88 |
|
|
2018
Q4 | $353K | Buy |
+1,174
| New | +$353K | 0.17% | 62 |
|